Company: MBIO
Filing Date: 2025-02-07
Form Type: 424B4
Source: 0001410578-25-000085
Chunk: 257

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-07
Form: 424B4
Chunk 257
---
31, 2023 and 2022, is presented below:

| ​                                   
 ​                                   
 ​                                   
 ​                                   
 ​                                   | ​ 
 ​ 
 ​ 
 ​ |        ​ 
        ​ 
        ​ 
        ​ 
 Warrants | ​ 
 ​ 
 ​ 
 ​ | ​                
 ​                
 ​                
 Weighted Average 
 Exercise Price   |        ​ 
        ​ 
        ​ | ​ 
 ​ 
 ​ 
 ​ |                    ​ 
     Weighted Average 
            Remaining 
 Contractual Life (in 
               years) |
|:------------------------------------|:--|---------:|:--|:-----------------|---------:|:--|---------------------:|
| Outstanding as of December 31, 2021 |   |    4,393 | ​ | $                | 6,036.53 |   |                 0.73 |
| Expired                             | ​ |   -4,003 | ​ | ​                | 6,375.00 | ​ |                    — |
| Granted                             |   |      997 | ​ |                  |   601.58 |   |                 9.18 |
| Outstanding as of December 31, 2022 |   |    1,387 | ​ | $                | 1,152.94 |   |                 8.29 |
| Exercised                           |   |       -1 | ​ |                  |     0.08 |   |                    — |
| Granted                             |   |   88,232 | ​ |                  |    50.09 |   |                 5.29 |
| Outstanding as of December 31, 2023 |   |   89,618 | ​ | $                |    67.16 |   |                 5.34 |

Upon the exercise of warrants, the Company will issue new shares of Common Stock. Employee Stock Purchase Plan In connection with our Employee Stock Purchase Plan (“ESPP”), eligible employees of Mustang and Fortress can purchase the Company’s Common Stock at the end of a predetermined offering period at 85% of the lower of the fair market value at the beginning or end of the offering period. As of December 31, 2023, 1,727 shares have been purchased and 7,606 shares are available for future sale under the Company’s ESPP. Note 10 – Income Taxes The Company has accumulated net losses since inception and has not recorded an income tax provision or benefit during the